期刊文献+

GW4064对果糖诱导非酒精性脂肪肝小鼠的保护作用研究 被引量:3

Protective Effect of GW4064 on Non-alcoholic Fatty Liver Induced by Fructose in Mice
下载PDF
导出
摘要 目的:研究GW4064对果糖诱导非酒精性脂肪肝(NAFLD)小鼠的保护作用。方法:小鼠随机分为正常对照组、模型组和治疗组,采用30%果糖水造模,8周后,治疗组灌胃给予GW4064(30 mg·kg^(-1)),2周后测定各组小鼠血清中葡萄糖、胰岛素、低密度脂蛋白胆固醇(LDL-C)、高密度脂蛋白胆固醇(HDL-C)、三酰甘油(TG)和胆固醇(CHO)水平;观察肝脏病理改变。结果:与NAFLD模型组相比,GW4064组小鼠空腹血糖及胰岛素含量降低,血清中TG、CHO和LDL-C含量显著降低,HDL-C水平显著升高。病理结果显示,GW4064能显著降低NAFLD小鼠肝脏脂肪变性,明显减轻肝脏损伤程度。结论:采用30%果糖可以成功诱导NAFLD模型,GW4064通过降低脂质沉积和增加胰岛素敏感性来改善NAFLD。 Objective: To investigate the protective effect of GW4064 on the non-alcoholic fatty liver (NAFLD) induced by fructose in mice. Methods: The mice were randomly divided into the normal control group, the model control group and GW4064 group. The model was established by feeding 30% fructose for 8 weeks, and then given GW4064 (30 mg · kg-1 ) for two weeks. The levels of fasting serum glucose, fasting insulin, triglyceride (TG), cholesterol (CHO), low density lipoprotein cholesterol (LDL-C) and high density lipoprotein cholesterol (HDL-C) were detected. Liver histopathological changes were observed by oil red O staining and hema- toxylin eosin (HE) staining. Results: Compared with those in the model group, the levels of fasting serum glucose, fasting insulin, TG, CHO and LDL-C were significantly decreased, and the content of HDL-C was increased after GW4064 treatment (P 〈 0.05). The histopathologieal examination showed that the degree of liver steatosis was improved, and the liver injury was alleviated significantly in GW4064 group. Conclusion: The NAFLD model is successfully established by 30% fructose. GW4064 can exhibit the protective effect on the NAFLD in mice. The possible mechanism is associated with the improvement of insulin resistance and the decrease of blood and liver lipids.
出处 《中国药师》 CAS 2016年第1期17-21,共5页 China Pharmacist
基金 湖北省自然科学基金重点项目(编号:2014CFA087)
关键词 GW4064 非酒精性脂肪肝 果糖 FXR受体 脂质代谢 GW4064 Non-alcoholic fatty liver disease Fructose FXR receptor Lipid metabolism
  • 相关文献

参考文献21

  • 1Schwimmer JB, Deutseh R, Kahen T, et al. Prevalem~e of fatty liver in children and adolescents[J]. Pediatrics, 2006, 118 (4): 1388-1393.
  • 2Gulefia A, Duseja A, Kalra N, et al. Patients with non-alcoholic fatty liver disease( NAFLD ) have an increased risk of atherosclerosls and cardiovascular disease[J]. Trop Gastroenterol, 2013, 34 (2) : 74-82.
  • 3Ying I, Saposnik G, Vermeulen MJ, et al. Nonalcoholic fatty liver dis- ease and acute ischemic stroke [J]. Epidemiology, 2011 , 22 ( 1 ) : 129-130.
  • 4张丹丹,但汉雄,黄慧辉,吴欢欢,刘焱文,叶晓川.火麻仁油对高脂血症大鼠血脂代谢及保肝作用研究[J].中国药师,2015,18(4):571-573. 被引量:17
  • 5Li Y, Jadhav K, Zhang Y. Bile acid receptors in non-alcoholic rally liver disease[J]. Biochem Phartno~ol, 2013, 86 (11) : 1517-1524.
  • 6Porez G, Gross B, Prawitt J, et al. The hepatic on~somucoid/alphal- acid glycoprotein gene cluster is regulated by the nuclem" bile acid r~'- ceptor FXR[J]. Endocrinology, 2013, 154 (10) : 3690-3701.
  • 7Zhang Y, Yin L, Anderson J, et al. Identification of novel pathways that control farnesoid X receptor-mediated hypoeholesterolemia [ J ]. J Biol Chem, 2010, 285 (5) : 3035-3043.
  • 8Schmitt J, Kong B, Stieger B, et al. Protective effects of farnesoid Xreceptor (FXR) on hepatic lipid accumulation are mediated by hepatic FXR and independent of intestinal FGF15 signal[J]. Liver lnt, 2015, 35 (4): 1133-1144.
  • 9Cipriani S, Mencarelli A, Palladino G, et al. FXR activation reverses insulin resistance and lipid abnormalities and protects against liver steatosis in Zucker (fa/fa) obese rats[J]. J Lipid Res, 2010, 51 (4) : 771-784.
  • 10Adorini L, Pmzanski M, Shapiro D. Farnesoid X receptor targeting to treat nonalcoholic steatohepatitis [ J ]. Drug Discov Today, 2012, 17 (17-18) : 988-997.

二级参考文献12

共引文献16

同被引文献21

引证文献3

二级引证文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部